RAC supplies reference standards for 6 Levodopa impurities, including Levodopa Impurity 12 and Levodopa Impurity 17. Every lot is released with a certificate stating HPLC purity, MS and 1H NMR data, produced under ISO 17034:2016 (ANAB, AR-2832). All items are scheduled on synthesis, typically 3-4 weeks. Pharmacopoeial items follow the monograph numbering (EP, USP, BP); non-pharmacopoeial items are characterised against the drawn structure, and can be re-qualified against your own method on request.
| 标准品 | CAS | 状态 | |
|---|---|---|---|
| Levodopa Impurity 12 | 25520-73-4 | 合成中 | |
| Levodopa Impurity 17 | 27313-65-1 | 合成中 | |
| Levodopa Impurity 18 | 33605-56-0 | 合成中 | |
| Levodopa Impurity 8 | 4790-08-3 | 合成中 | |
| Levodopa Impurity N1 | 1421-65-4 | 合成中 | |
| Levodopa Impurity N2 | 55-59-4 | 合成中 |
Prices are quoted per enquiry — pack size, documentation and shipping are confirmed together.
Metabolites, NDSRI 亚硝胺s and degradation products of Levodopa that no catalogue lists — typically 3–4 weeks from 10 mg to gram scale, released with the same certificate.